The most commonly used prostate cancer screening procedure, PSA, is at the center of a growing debate after its discoverer said it had become a "hugely expensive public health disaster."

Endo Pharma hires former Nora Therapeutics and J&J exec McHugh as chief operating officer. Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer.

Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system.

Experts say Americans getting too many medical tests, maybe even President Obama. Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggests that many Americans are being overtreated. Maybe even President Barack Obama, champion of an overhaul and cost-cutting of the health care system.

Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often:

Are some medical tests overused? Some guidelines are scaling back on frequency, timing. Recent reports and guideline changes suggest some medical tests should be delayed, avoided, or done less often:

Watson Pharmaceuticals says FDA approves 6-month dose of prostate cancer drug Trelstar. Watson Pharmaceuticals Inc. said the Food and Drug Administration approved a six-month dose of the prostate cancer drug Trelstar, which already was available in one- and three-month doses.

WASHINGTON (Reuters) - The most commonly used tool for detecting prostate cancer, routine PSA screening, has become "a hugely expensive public health disaster," its discoverer said on Wednesday.

NEW YORK (Reuters Health) - New research suggests that the type of specialist a prostate cancer patient sees -- rather than the patient's own preference -- may determine the treatment he receives.

Johnny Alf, a founder of Brazil's Bossa Nova music and aficionado of early jazz, dies at 80. A founder of Bossa Nova music has died in Brazil after fighting prostate cancer. He was 80.

FDA says Takeda has agreed to rename Kapidex to avoid confusion with other drugs. Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.

FDA says Takeda has agreed to rename Kadipex to avoid confusion with other drugs. Federal regulators say Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.

American Cancer Society casts more doubt on value of regular testing for prostate cancer. Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.

Months after experts discounted the importance of routine mammograms and Pap smears for many women, the American Cancer Society is warning more explicitly than ever that regular testing for prostate cancer is of questionable value too, and can do men more harm than good.

For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.

Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds. For the first time, an experimental drug has extended the lives of men with advanced prostate cancer who are no longer responding to other treatments and are out of options for fighting the disease, a company-led study found.

A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.

Experimental drug modestly boosts survival in men with advanced prostate cancer, study finds. A study suggests that an experimental drug may modestly extend the lives of men with advanced prostate cancer who are no longer responding to other treatments.

The American Cancer Society revised its guidelines for prostate cancer screening on Wednesday. The advocacy group is one of many organizations that make such recommendations. Some questions and answers:

New advice on prostate cancer screening stresses talking about pros, cons before deciding. The American Cancer Society revised its guidelines for prostate cancer screening on Wednesday. The advocacy group is one of many organizations that make such recommendations. Some questions and answers: